title: Maspin expression in carcinoma ex pleomorphic adenoma.
abstract: OBJECTIVE
  To investigate the presence and distribution of the protein maspin in carcinoma ex pleomorphic adenoma (CXPA).
  
  
  METHODS
  Maspin expression was studied by means of immunohistochemistry in 16 cases of CXPA, using the labelled polymer method.
  
  
  RESULTS
  According to the extent of invasion, the tumours were subdivided into: intracapsular (five cases), minimally invasive (four cases), and invasive (seven cases). Twelve patients had carcinoma with only epithelial differentiation, whereas four had a malignant myoepithelial component. Non-luminal cells in the duct-like structures of the remnant pleomorphic adenoma were strongly positive for maspin, whereas only a few luminal cells were immunopositive. A few positive cells were seen in the frequent hypocellular and hyalinised areas. Maspin was abundantly expressed, mainly in non-luminal cells, in transitional areas of CXPA with only epithelial differentiation. In frankly carcinomatous areas there was a gradual decrease in maspin expression. Almost all cells were maspin positive in CXPA with a myoepithelial component. When present, luminal cells were in general negative for maspin.
  
  
  CONCLUSIONS
  When only epithelial cells undergo malignant transformation, maspin expression is gradually lost. In cases with a myoepithelial component, maspin expression is high, and this might be related to the tumour suppressor activity attributed to this cell.
authors.affiliation: Department of Oral Pathology, School of Dentistry, University of São Paulo, 05508-900 São Paulo, SP, Brazil. mariliam@usp.br
authors.forename: M T
authors.initials: MT
authors.lastname: Martins
authors.forename: A
authors.initials: A
authors.lastname: Altemani
authors.forename: L
authors.initials: L
authors.lastname: Freitas
authors.forename: V C
authors.initials: VC
authors.lastname: Araújo
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology; D008949:Adenoma, Pleomorphic / Q000378:metabolism* / Q000473:pathology; D002454:Cell Differentiation; D018450:Disease Progression; D016147:Genes, Tumor Suppressor; D006801:Humans; D009208:Myoepithelioma / Q000378:metabolism / Q000473:pathology; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000378:metabolism*; D012468:Salivary Gland Neoplasms / Q000378:metabolism* / Q000473:pathology; D015843:Serpins / Q000378:metabolism*
chemical_list: D009363:Neoplasm Proteins; C085344:SERPIN-B5; D015843:Serpins